Combination of agonistic CD40 monoclonal antibody CP-870,893 and anti-CTLA-4 antibody tremelimumab in patients with metastatic melanoma

被引：15
|
作者：
Bajor, David L. [1 ]
Mick, Rosemarie [1 ]
Riese, Matthew J. [1 ]
Richman, Lee P. [1 ]
Xu, Xiaowei [1 ]
Torigian, Drew A. [1 ]
Stelekati, Erietta [1 ]
Sweeney, Martha [1 ]
Sullivan, Brendan [1 ]
Schuchter, Lynn M. [1 ]
Amaravadi, Ravi [1 ]
Wherry, E. John [1 ]
Vonderheide, Robert H. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-CT137
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT137
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Phase I study of combination immunotherapy with agonistic CD40 monoclonal antibody (mAb) CP-870,893 (aCD40) and anti-CTLA-4 antibody tremelimumab (treme) in patients with metastatic melanoma
    Bajor, David L.
    Mick, Rosemarie
    Riese, Matthew J.
    Lee, Richman P.
    Xu, Xiaowei
    Torigian, Drew A.
    Stelekati, Erietta
    Sweeney, Martha
    Sullivan, Brendan J.
    Schuchter, Lynn M.
    Amaravadi, Ravi
    Wherry, E. John
    Vonderheide, Robert H.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [2] Soluble CD25 and C-reactive protein predict overall survival in melanoma patients receiving anti-CD40 monoclonal antibody CP-870,893 (αCD40) and anti-CTLA4 monoclonal antibody tremelimumab
    Mick, Rosemarie
    Bajor, David
    Richman, Lee
    Vonderheide, Robert
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [3] A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma
    Beatty, Gregory L.
    Torigian, Drew A.
    Chiorean, E. Gabriela
    Saboury, Babak
    Brothers, Alex
    Alavi, Abass
    Troxel, Andrea B.
    Sun, Weijing
    Teitelbaum, Ursina R.
    Vonderheide, Robert H.
    O'Dwyer, Peter J.
    CLINICAL CANCER RESEARCH, 2013, 19 (22) : 6286 - 6295
  • [4] Surface expression of CD40 on human melanoma and the direct in vitro growth effects of an anti-CD40 agonist antibody, CP-870,893
    Kalbasi, A.
    Chmielowski, B.
    Ribas, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 223 - 224
  • [5] Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody
    Vonderheide, Robert H.
    Flaherty, Keith T.
    Khalil, Magi
    Stumacher, Molly S.
    Bajor, David L.
    Hutnick, Natalie A.
    Sullivan, Patricia
    Mahany, J. Joseph
    Gallagher, Maryann
    Kramer, Amy
    Green, Stephanie J.
    O'Dwyer, Peter J.
    Running, Kelli L.
    Huhn, Richard D.
    Antonia, Scott J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 876 - 883
  • [6] A phase I study of CD40 agonist monoclonal antibody (CP-870,893) with gemcitabine in pancreatic cancer.
    Beatty, G. L.
    Chiorean, E. G.
    Torigian, D. A.
    Teitelbaum, U. R.
    Sun, W.
    Fly, K. D.
    Huhn, R. D.
    Vonderheide, R. H.
    O'Dwyer, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] CD40 Expression by Human Melanocytic Lesions and Melanoma Cell Lines and Direct CD40 Targeting With the Therapeutic Anti-CD40 Antibody CP-870,893
    Kalbasi, Anusha
    Fonsatti, Ester
    Natali, Pier Giorgio
    Altomonte, Maresa
    Bertocci, Erica
    Cutaia, Ornella
    Calabro, Luana
    Chiou, Michael
    Tap, William
    Chmielowski, Bartosz
    Maio, Michele
    Ribas, Antoni
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 810 - 816
  • [8] Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
    Vonderheide, R. H.
    Flaherty, K. T.
    Khalil, M.
    Stumacher, M. S.
    Bajor, D. L.
    Gallagher, M.
    Sullivan, P.
    Mahaney, J. J.
    O'Dwyer, P. J.
    Huhn, R. D.
    Antonia, S. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 101S - 101S
  • [9] Phase I study of the CD40 agonist antibody CP-870,893 combined with carboplatin and paclitaxel in patients with advanced solid tumors
    Vonderheide, Robert H.
    Burg, Jennifer M.
    Mick, Rosemarie
    Trosko, Jennifer A.
    Li, Dongguang
    Shaik, M. Naveed
    Tolcher, Anthony W.
    Hamid, Omid
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [10] Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma
    Lipson, Evan J.
    Drake, Charles G.
    CLINICAL CANCER RESEARCH, 2011, 17 (22) : 6958 - 6962
12345